Eterna Therapeutics Inc.·4

Feb 10, 7:00 PM ET

Luther Sanjeev 4

4 · Eterna Therapeutics Inc. · Filed Feb 10, 2025

Insider Transaction Report

Form 4
Period: 2025-02-07
Luther Sanjeev
DirectorPresident & CEO
Transactions
  • Award

    Stock Option (right to buy)

    2025-02-07+1,123,3501,123,350 total
    Exercise: $0.34Exp: 2035-02-07Common Stock (1,123,350 underlying)
Footnotes (1)
  • [F1]Subject to continued service, one-third of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 24 substantially equal monthly installments thereafter.

Documents

1 file
  • 4
    ownership.xmlPrimary